transfection ac16 human cardiomyocytes Search Results


90
BioVector Inc human cardiomyocytes (ac16)
The expression of circ_0124644 in AMI patients and hypoxia-induced <t>AC16</t> cells. (A) The circ_0124644 expression in the serum of AMI patients and healthy control volunteers was measured using qRT-PCR. (B) The expression of circ_0124644 was detected using qRT-PCR in hypoxia-treated and normoxia-treated AC16 cells. RNase R assay (C) and Act D assay (D) were used to confirm the stability of circ_0124644. (E) Subcellular localization analysis was performed to assess the distribution of circ_0124644 in the cytoplasm and nuclear of AC16 cells. ** P < 0.01, *** P < 0.001.
Human Cardiomyocytes (Ac16), supplied by BioVector Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transfection+ac16+human+cardiomyocytes/human+cardiomyocytes++ac16+/pmc08267871-34-0-3
Average 90 stars, based on 1 article reviews
human cardiomyocytes (ac16) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

97
ATCC human cardiomyocytes
The expression of circ_0124644 in AMI patients and hypoxia-induced <t>AC16</t> cells. (A) The circ_0124644 expression in the serum of AMI patients and healthy control volunteers was measured using qRT-PCR. (B) The expression of circ_0124644 was detected using qRT-PCR in hypoxia-treated and normoxia-treated AC16 cells. RNase R assay (C) and Act D assay (D) were used to confirm the stability of circ_0124644. (E) Subcellular localization analysis was performed to assess the distribution of circ_0124644 in the cytoplasm and nuclear of AC16 cells. ** P < 0.01, *** P < 0.001.
Human Cardiomyocytes, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transfection+ac16+human+cardiomyocytes/AC16/pmc10985082-178-0-10
Average 97 stars, based on 1 article reviews
human cardiomyocytes - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

86
Procell Inc ac16 human cardiomyocytes
The expression of circ_0124644 in AMI patients and hypoxia-induced <t>AC16</t> cells. (A) The circ_0124644 expression in the serum of AMI patients and healthy control volunteers was measured using qRT-PCR. (B) The expression of circ_0124644 was detected using qRT-PCR in hypoxia-treated and normoxia-treated AC16 cells. RNase R assay (C) and Act D assay (D) were used to confirm the stability of circ_0124644. (E) Subcellular localization analysis was performed to assess the distribution of circ_0124644 in the cytoplasm and nuclear of AC16 cells. ** P < 0.01, *** P < 0.001.
Ac16 Human Cardiomyocytes, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transfection+ac16+human+cardiomyocytes/ac16+cells/pm41594941-101-7-13
Average 86 stars, based on 1 article reviews
ac16 human cardiomyocytes - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology anti hsp90
The expression of circ_0124644 in AMI patients and hypoxia-induced <t>AC16</t> cells. (A) The circ_0124644 expression in the serum of AMI patients and healthy control volunteers was measured using qRT-PCR. (B) The expression of circ_0124644 was detected using qRT-PCR in hypoxia-treated and normoxia-treated AC16 cells. RNase R assay (C) and Act D assay (D) were used to confirm the stability of circ_0124644. (E) Subcellular localization analysis was performed to assess the distribution of circ_0124644 in the cytoplasm and nuclear of AC16 cells. ** P < 0.01, *** P < 0.001.
Anti Hsp90, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transfection+ac16+human+cardiomyocytes/HSP+90+Antibody/pm33941656-54-5-21
Average 96 stars, based on 1 article reviews
anti hsp90 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
GeneDireX Inc human ventricular cardiomyocyte cells ac16
Differentially expressed genes in human <t>cardiomyocytes.</t> Numbers of differentially expressed genes after cyclic stretching: ( A ) Genes showing an at least 2-fold difference in expression; ( B ) genes showing an at least 1.5-fold difference in expression. Venn diagrams show the overlapping genes with at least 2-fold and 1.5-fold differences in expression.
Human Ventricular Cardiomyocyte Cells Ac16, supplied by GeneDireX Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transfection+ac16+human+cardiomyocytes/human+ventricular+cardiomyocyte+cells+ac16/pmc07485730-78-0-9
Average 90 stars, based on 1 article reviews
human ventricular cardiomyocyte cells ac16 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
EpiCypher h3k4 9 14 18ac
Comparison of “standard” and “high-resolution” CZE methods. Extracted Ion Electropherograms (EIEs, seven highest charge states each) of sample containing H2BK120ub and <t>H3K4,9,14,18ac</t> analyzed with (a) standard and (b) high-resolution CZE method. Mass spectra (c-f) generated by averaging the EIE peaks at full width at half maximum (FWHM). Partial separation (R = 0.366, n = 2) obtained using standard method and close to baseline separation (R = 1.082, n = 3) achieved for high-resolution method.
H3k4 9 14 18ac, supplied by EpiCypher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transfection+ac16+human+cardiomyocytes/Nucleosome%2C+Recombinant+Human%2C+H3K4%2C9%2C14%2C18ac+dNuc+Biotinylated/bio_rxiv__2020__11__25__398925-39-18-5
Average 93 stars, based on 1 article reviews
h3k4 9 14 18ac - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Merck KGaA ac16 cardiomyocytes
( A ) Mice underwent sham surgery, STNx, or IRI and were sacrificed at 70 or 147 days after surgery. ( B ) Serum urea, serum creatinine (S-creatinine), heart weight, normalized to tibia length, and ejection fraction at the time point of sacrifice in sham (SH), STNx, and IRI mice. ( C ) Representative trichrome-stained images of kidney and heart. Scale bars, 50 μm. ( D ) UMAP embedding of nuclei isolated from left ventricle of all mice. n = 33,039 nuclei from n = 12 mice. ( E ) Expression of marker genes per cluster <t>(cardiomyocytes:</t> Ryr2 , Dmd , Myh6 , Fhl2 , and Ttn ; endothelial cells: Vwf , Cgnl1 , Smoc1 , Bmx , Pecam1 , Flt1 , Adgrl1 , and Prprb ; fibroblasts: Pdgra , Egfr , Dcn , Gsn , Col3a1 , and Col8a1 ; lymphatic endothelial cells: Flt4 , Prox1 , Lyve1 , and Pdpn ; lymphocytes: Btla , Cd2 , Bcl11b , and Sell ; macrophages: Mrc1 , Lyz2 , Cd86 , Cd68 , and Cd80 ; mesothelial cells: Muc16 , Msln , and Upk3b ; monocytes: Cd45 , Csfr1r; RBC: Lock2 , and Cd36 ; pericytes: Pdgfrb , Notch3 , Mcam , and Rgs5 ; and VSMC : Myh11 , Myl9 , and Lmod ). ( F ) PROGENGY pathway analysis in all cell types, STNx versus sham and IRI versus sham. ( G ) Predicted receptor-ligand interactions per group, sham, STNx, and IRI. * P < 0.05; ** P < 0.001. CM, cardiomyocytes; EC, endothelial cells; Fib, fibroblasts; Lym, lymphocytes; LEC, lymphatic endothelial cells; Mac, macrophages; Mes, mesothelial cells; Mon, monocytes; Per, pericytes; RBC, red blood cells; VSMC, vascular smooth muscle cells.
Ac16 Cardiomyocytes, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transfection+ac16+human+cardiomyocytes/ac16+human+cardiomyocyte+cell+line/pmc10672229-318-0-3
Average 90 stars, based on 1 article reviews
ac16 cardiomyocytes - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
Procell Inc human cardiomyocytes
( A ) Mice underwent sham surgery, STNx, or IRI and were sacrificed at 70 or 147 days after surgery. ( B ) Serum urea, serum creatinine (S-creatinine), heart weight, normalized to tibia length, and ejection fraction at the time point of sacrifice in sham (SH), STNx, and IRI mice. ( C ) Representative trichrome-stained images of kidney and heart. Scale bars, 50 μm. ( D ) UMAP embedding of nuclei isolated from left ventricle of all mice. n = 33,039 nuclei from n = 12 mice. ( E ) Expression of marker genes per cluster <t>(cardiomyocytes:</t> Ryr2 , Dmd , Myh6 , Fhl2 , and Ttn ; endothelial cells: Vwf , Cgnl1 , Smoc1 , Bmx , Pecam1 , Flt1 , Adgrl1 , and Prprb ; fibroblasts: Pdgra , Egfr , Dcn , Gsn , Col3a1 , and Col8a1 ; lymphatic endothelial cells: Flt4 , Prox1 , Lyve1 , and Pdpn ; lymphocytes: Btla , Cd2 , Bcl11b , and Sell ; macrophages: Mrc1 , Lyz2 , Cd86 , Cd68 , and Cd80 ; mesothelial cells: Muc16 , Msln , and Upk3b ; monocytes: Cd45 , Csfr1r; RBC: Lock2 , and Cd36 ; pericytes: Pdgfrb , Notch3 , Mcam , and Rgs5 ; and VSMC : Myh11 , Myl9 , and Lmod ). ( F ) PROGENGY pathway analysis in all cell types, STNx versus sham and IRI versus sham. ( G ) Predicted receptor-ligand interactions per group, sham, STNx, and IRI. * P < 0.05; ** P < 0.001. CM, cardiomyocytes; EC, endothelial cells; Fib, fibroblasts; Lym, lymphocytes; LEC, lymphatic endothelial cells; Mac, macrophages; Mes, mesothelial cells; Mon, monocytes; Per, pericytes; RBC, red blood cells; VSMC, vascular smooth muscle cells.
Human Cardiomyocytes, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transfection+ac16+human+cardiomyocytes/cardiomyocytes+human/10__1016_slash_j__curpro__2026__100079-47-0-3
Average 86 stars, based on 1 article reviews
human cardiomyocytes - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Merck & Co ac16 human ventricular cardiomyocytes
( A ) Mice underwent sham surgery, STNx, or IRI and were sacrificed at 70 or 147 days after surgery. ( B ) Serum urea, serum creatinine (S-creatinine), heart weight, normalized to tibia length, and ejection fraction at the time point of sacrifice in sham (SH), STNx, and IRI mice. ( C ) Representative trichrome-stained images of kidney and heart. Scale bars, 50 μm. ( D ) UMAP embedding of nuclei isolated from left ventricle of all mice. n = 33,039 nuclei from n = 12 mice. ( E ) Expression of marker genes per cluster <t>(cardiomyocytes:</t> Ryr2 , Dmd , Myh6 , Fhl2 , and Ttn ; endothelial cells: Vwf , Cgnl1 , Smoc1 , Bmx , Pecam1 , Flt1 , Adgrl1 , and Prprb ; fibroblasts: Pdgra , Egfr , Dcn , Gsn , Col3a1 , and Col8a1 ; lymphatic endothelial cells: Flt4 , Prox1 , Lyve1 , and Pdpn ; lymphocytes: Btla , Cd2 , Bcl11b , and Sell ; macrophages: Mrc1 , Lyz2 , Cd86 , Cd68 , and Cd80 ; mesothelial cells: Muc16 , Msln , and Upk3b ; monocytes: Cd45 , Csfr1r; RBC: Lock2 , and Cd36 ; pericytes: Pdgfrb , Notch3 , Mcam , and Rgs5 ; and VSMC : Myh11 , Myl9 , and Lmod ). ( F ) PROGENGY pathway analysis in all cell types, STNx versus sham and IRI versus sham. ( G ) Predicted receptor-ligand interactions per group, sham, STNx, and IRI. * P < 0.05; ** P < 0.001. CM, cardiomyocytes; EC, endothelial cells; Fib, fibroblasts; Lym, lymphocytes; LEC, lymphatic endothelial cells; Mac, macrophages; Mes, mesothelial cells; Mon, monocytes; Per, pericytes; RBC, red blood cells; VSMC, vascular smooth muscle cells.
Ac16 Human Ventricular Cardiomyocytes, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transfection+ac16+human+cardiomyocytes/ac16/pm39539181-39-6-10
Average 90 stars, based on 1 article reviews
ac16 human ventricular cardiomyocytes - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Merck & Co human cardiomyocytes
Protection of hypoxic human <t>cardiomyocytes</t> using CMSCLC and BM-MSC EVs ( A ) Experimental design showing hiPSC-CM seeding and hypoxia treatment. ( B ) Example images of hiPSC-CMs following 48 h normoxia or hypoxia + vehicle (Veh), or hypoxia with 67 ng/µl CMSCLC EVs (C_EVs) or BM-MSC EVs (B_EVs). Scale bar 100 μm. ( C ) Culture medium LDH levels after 48 h of hiPSC-CM exposure to each treatment group. Blank samples (without hiPSC-CMs) are also included. Hypoxic hiPSC-CM groups were compared by one-way ANOVA with Tukey’s multiple comparison test. *** = P ≤ 0.001, **** = P ≤ 0.0001 ( D ) Apoptosis protein arrays from each group ( n = 2 per group). Examples of significant differences between samples are highlighted with red boxes. Positive controls are shown as blue boxes in the upper left and lower right corners. ( E ) Heatmap showing quantification of integrated density of high concentration apoptosis-related proteins ( n = 2 per group). All groups were compared using two-way ANOVA with Tukey’s post-test. The table above the heat map describes statistical significance; 1 = P < 0.05, 2 = P ≤ 0.01, 3 = P ≤ 0.001, 4 = P ≤ 0.0001, ns = not significant ( P > 0.05)
Human Cardiomyocytes, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transfection+ac16+human+cardiomyocytes/human+cardiomyocytes/pmc11470622-77-8-11
Average 90 stars, based on 1 article reviews
human cardiomyocytes - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Servicebio Inc human cardiomyocytes (ac16)
Protection of hypoxic human <t>cardiomyocytes</t> using CMSCLC and BM-MSC EVs ( A ) Experimental design showing hiPSC-CM seeding and hypoxia treatment. ( B ) Example images of hiPSC-CMs following 48 h normoxia or hypoxia + vehicle (Veh), or hypoxia with 67 ng/µl CMSCLC EVs (C_EVs) or BM-MSC EVs (B_EVs). Scale bar 100 μm. ( C ) Culture medium LDH levels after 48 h of hiPSC-CM exposure to each treatment group. Blank samples (without hiPSC-CMs) are also included. Hypoxic hiPSC-CM groups were compared by one-way ANOVA with Tukey’s multiple comparison test. *** = P ≤ 0.001, **** = P ≤ 0.0001 ( D ) Apoptosis protein arrays from each group ( n = 2 per group). Examples of significant differences between samples are highlighted with red boxes. Positive controls are shown as blue boxes in the upper left and lower right corners. ( E ) Heatmap showing quantification of integrated density of high concentration apoptosis-related proteins ( n = 2 per group). All groups were compared using two-way ANOVA with Tukey’s post-test. The table above the heat map describes statistical significance; 1 = P < 0.05, 2 = P ≤ 0.01, 3 = P ≤ 0.001, 4 = P ≤ 0.0001, ns = not significant ( P > 0.05)
Human Cardiomyocytes (Ac16), supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transfection+ac16+human+cardiomyocytes/ac16+cells+stcc13101p/pm40221727-94-16-23
Average 90 stars, based on 1 article reviews
human cardiomyocytes (ac16) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
Merck & Co ac16 human cardiomyocyte cell line
Protection of hypoxic human <t>cardiomyocytes</t> using CMSCLC and BM-MSC EVs ( A ) Experimental design showing hiPSC-CM seeding and hypoxia treatment. ( B ) Example images of hiPSC-CMs following 48 h normoxia or hypoxia + vehicle (Veh), or hypoxia with 67 ng/µl CMSCLC EVs (C_EVs) or BM-MSC EVs (B_EVs). Scale bar 100 μm. ( C ) Culture medium LDH levels after 48 h of hiPSC-CM exposure to each treatment group. Blank samples (without hiPSC-CMs) are also included. Hypoxic hiPSC-CM groups were compared by one-way ANOVA with Tukey’s multiple comparison test. *** = P ≤ 0.001, **** = P ≤ 0.0001 ( D ) Apoptosis protein arrays from each group ( n = 2 per group). Examples of significant differences between samples are highlighted with red boxes. Positive controls are shown as blue boxes in the upper left and lower right corners. ( E ) Heatmap showing quantification of integrated density of high concentration apoptosis-related proteins ( n = 2 per group). All groups were compared using two-way ANOVA with Tukey’s post-test. The table above the heat map describes statistical significance; 1 = P < 0.05, 2 = P ≤ 0.01, 3 = P ≤ 0.001, 4 = P ≤ 0.0001, ns = not significant ( P > 0.05)
Ac16 Human Cardiomyocyte Cell Line, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transfection+ac16+human+cardiomyocytes/cardiomyocytes+human+ventricular/us12429489-178-0-9
Average 86 stars, based on 1 article reviews
ac16 human cardiomyocyte cell line - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


The expression of circ_0124644 in AMI patients and hypoxia-induced AC16 cells. (A) The circ_0124644 expression in the serum of AMI patients and healthy control volunteers was measured using qRT-PCR. (B) The expression of circ_0124644 was detected using qRT-PCR in hypoxia-treated and normoxia-treated AC16 cells. RNase R assay (C) and Act D assay (D) were used to confirm the stability of circ_0124644. (E) Subcellular localization analysis was performed to assess the distribution of circ_0124644 in the cytoplasm and nuclear of AC16 cells. ** P < 0.01, *** P < 0.001.

Journal: Frontiers in Genetics

Article Title: Circ_0124644 Serves as a ceRNA for miR-590-3p to Promote Hypoxia-Induced Cardiomyocytes Injury via Regulating SOX4

doi: 10.3389/fgene.2021.667724

Figure Lengend Snippet: The expression of circ_0124644 in AMI patients and hypoxia-induced AC16 cells. (A) The circ_0124644 expression in the serum of AMI patients and healthy control volunteers was measured using qRT-PCR. (B) The expression of circ_0124644 was detected using qRT-PCR in hypoxia-treated and normoxia-treated AC16 cells. RNase R assay (C) and Act D assay (D) were used to confirm the stability of circ_0124644. (E) Subcellular localization analysis was performed to assess the distribution of circ_0124644 in the cytoplasm and nuclear of AC16 cells. ** P < 0.01, *** P < 0.001.

Article Snippet: Human cardiomyocytes (AC16) (Biovector National Typical Culture Center, Beijing, China) were cultured in DMEM medium (Gibco, Grand Island, NY, United States) containing 10% fetal bovine serum (FBS; Gibco) and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, United States).

Techniques: Expressing, Control, Quantitative RT-PCR

The regulation of circ_0124644 silencing on hypoxia-induced cardiomyocytes injury. (A) AC16 cells were transfected with sh-NC or sh-circ_0124644. The expression of circ_0124644 was measured by qRT-PCR. (B–I) AC16 cells were transfected with sh-NC or sh-circ_0124644, followed by treated with hypoxia. AC16 cells treated with normoxia were used as control. (B) CCK8 assay was used to examine cell viability. (C,D) Flow cytometry was performed to detect cell cycle distribution and cell apoptosis. (E) The protein levels of CyclinD1 and Cleaved-casp3 were determined using WB analysis. (F–I) Corresponding Assay Kits were used to assess the levels of LDH, MDA, SOD, and CAT. ** P < 0.01, *** P < 0.001.

Journal: Frontiers in Genetics

Article Title: Circ_0124644 Serves as a ceRNA for miR-590-3p to Promote Hypoxia-Induced Cardiomyocytes Injury via Regulating SOX4

doi: 10.3389/fgene.2021.667724

Figure Lengend Snippet: The regulation of circ_0124644 silencing on hypoxia-induced cardiomyocytes injury. (A) AC16 cells were transfected with sh-NC or sh-circ_0124644. The expression of circ_0124644 was measured by qRT-PCR. (B–I) AC16 cells were transfected with sh-NC or sh-circ_0124644, followed by treated with hypoxia. AC16 cells treated with normoxia were used as control. (B) CCK8 assay was used to examine cell viability. (C,D) Flow cytometry was performed to detect cell cycle distribution and cell apoptosis. (E) The protein levels of CyclinD1 and Cleaved-casp3 were determined using WB analysis. (F–I) Corresponding Assay Kits were used to assess the levels of LDH, MDA, SOD, and CAT. ** P < 0.01, *** P < 0.001.

Article Snippet: Human cardiomyocytes (AC16) (Biovector National Typical Culture Center, Beijing, China) were cultured in DMEM medium (Gibco, Grand Island, NY, United States) containing 10% fetal bovine serum (FBS; Gibco) and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, United States).

Techniques: Transfection, Expressing, Quantitative RT-PCR, Control, CCK-8 Assay, Flow Cytometry

Circ_0124644 acted as a sponge of miR-590-3p. (A) The predicted and mutated binding sites between miR-590-3p and circ_0124644 were exhibited. (B) The transfection efficiency of miR-590-3p mimic was confirmed by detecting miR-590-3p expression in AC16 cells using qRT-PCR. Dual-luciferase reporter assay (C) , RIP assay (D) , and RNA pull-down assay (E) were employed to assess the interaction between miR-590-3p and circ_0124644. (F) AC16 cells were transfected with sh-NC or sh-circ_0124644, followed by treated with hypoxia. AC16 cells treated with normoxia were used as control. The expression of miR-590-3p was examined by qRT-PCR. (G) The expression of miR-590-3p in the serum of AMI patients and healthy control volunteers was determined by qRT-PCR. (H) Pearson correlation analysis was used to assess the correlation between miR-590-3p and circ_0124644. ** P < 0.01, *** P < 0.001.

Journal: Frontiers in Genetics

Article Title: Circ_0124644 Serves as a ceRNA for miR-590-3p to Promote Hypoxia-Induced Cardiomyocytes Injury via Regulating SOX4

doi: 10.3389/fgene.2021.667724

Figure Lengend Snippet: Circ_0124644 acted as a sponge of miR-590-3p. (A) The predicted and mutated binding sites between miR-590-3p and circ_0124644 were exhibited. (B) The transfection efficiency of miR-590-3p mimic was confirmed by detecting miR-590-3p expression in AC16 cells using qRT-PCR. Dual-luciferase reporter assay (C) , RIP assay (D) , and RNA pull-down assay (E) were employed to assess the interaction between miR-590-3p and circ_0124644. (F) AC16 cells were transfected with sh-NC or sh-circ_0124644, followed by treated with hypoxia. AC16 cells treated with normoxia were used as control. The expression of miR-590-3p was examined by qRT-PCR. (G) The expression of miR-590-3p in the serum of AMI patients and healthy control volunteers was determined by qRT-PCR. (H) Pearson correlation analysis was used to assess the correlation between miR-590-3p and circ_0124644. ** P < 0.01, *** P < 0.001.

Article Snippet: Human cardiomyocytes (AC16) (Biovector National Typical Culture Center, Beijing, China) were cultured in DMEM medium (Gibco, Grand Island, NY, United States) containing 10% fetal bovine serum (FBS; Gibco) and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, United States).

Techniques: Binding Assay, Transfection, Expressing, Quantitative RT-PCR, Luciferase, Reporter Assay, Pull Down Assay, Control

The regulation of miR-590-3p overexpression on cardiomyocytes injury induced by hypoxia. AC16 cells were transfected with miR-NC or miR-590-3p mimic, followed by treated with hypoxia. Normoxia-treated AC16 cells were used as control. (A) Cell viability was determined using CCK8 assay. (B,C) Cell cycle distribution and cell apoptosis were detected by flow cytometry. (D) WB analysis was performed to evaluate the protein levels of CyclinD1 and Cleaved-casp3. (E–H) The levels of LDH, MDA, SOD, and CAT were determined using corresponding Assay Kits. ** P < 0.01, *** P < 0.001.

Journal: Frontiers in Genetics

Article Title: Circ_0124644 Serves as a ceRNA for miR-590-3p to Promote Hypoxia-Induced Cardiomyocytes Injury via Regulating SOX4

doi: 10.3389/fgene.2021.667724

Figure Lengend Snippet: The regulation of miR-590-3p overexpression on cardiomyocytes injury induced by hypoxia. AC16 cells were transfected with miR-NC or miR-590-3p mimic, followed by treated with hypoxia. Normoxia-treated AC16 cells were used as control. (A) Cell viability was determined using CCK8 assay. (B,C) Cell cycle distribution and cell apoptosis were detected by flow cytometry. (D) WB analysis was performed to evaluate the protein levels of CyclinD1 and Cleaved-casp3. (E–H) The levels of LDH, MDA, SOD, and CAT were determined using corresponding Assay Kits. ** P < 0.01, *** P < 0.001.

Article Snippet: Human cardiomyocytes (AC16) (Biovector National Typical Culture Center, Beijing, China) were cultured in DMEM medium (Gibco, Grand Island, NY, United States) containing 10% fetal bovine serum (FBS; Gibco) and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, United States).

Techniques: Over Expression, Transfection, Control, CCK-8 Assay, Flow Cytometry

Effects of miR-590-3p inhibitor and circ_0124644 silencing on hypoxia-induced cardiomyocytes injury. (A) AC16 cells were transfected with anti-NC or anti-miR-590-3p. MiR-590-3p expression was detected by qRT-PCR. (B–I) AC16 cells were transfected with sh-NC + anti-NC, sh-circ_0124644 + anti-NC, sh-circ_0124644 + anti-miR-590-3p, followed by treated with hypoxia. Normoxia-treated AC16 cells transfected with sh-NC + anti-NC were used as control. (B) CCK8 assay was employed to measure cell viability. (C,D) Cell cycle distribution and cell apoptosis were evaluated using flow cytometry. (E) The protein levels of CyclinD1 and Cleaved-casp3 were examined by WB analysis. (F–I) The levels of LDH, MDA, SOD, and CAT were analyzed by corresponding Assay Kits. ** P < 0.01, *** P < 0.001.

Journal: Frontiers in Genetics

Article Title: Circ_0124644 Serves as a ceRNA for miR-590-3p to Promote Hypoxia-Induced Cardiomyocytes Injury via Regulating SOX4

doi: 10.3389/fgene.2021.667724

Figure Lengend Snippet: Effects of miR-590-3p inhibitor and circ_0124644 silencing on hypoxia-induced cardiomyocytes injury. (A) AC16 cells were transfected with anti-NC or anti-miR-590-3p. MiR-590-3p expression was detected by qRT-PCR. (B–I) AC16 cells were transfected with sh-NC + anti-NC, sh-circ_0124644 + anti-NC, sh-circ_0124644 + anti-miR-590-3p, followed by treated with hypoxia. Normoxia-treated AC16 cells transfected with sh-NC + anti-NC were used as control. (B) CCK8 assay was employed to measure cell viability. (C,D) Cell cycle distribution and cell apoptosis were evaluated using flow cytometry. (E) The protein levels of CyclinD1 and Cleaved-casp3 were examined by WB analysis. (F–I) The levels of LDH, MDA, SOD, and CAT were analyzed by corresponding Assay Kits. ** P < 0.01, *** P < 0.001.

Article Snippet: Human cardiomyocytes (AC16) (Biovector National Typical Culture Center, Beijing, China) were cultured in DMEM medium (Gibco, Grand Island, NY, United States) containing 10% fetal bovine serum (FBS; Gibco) and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, United States).

Techniques: Transfection, Expressing, Quantitative RT-PCR, Control, CCK-8 Assay, Flow Cytometry

SOX4 could be targeted by miR-590-3p. (A) The predicted and mutated binding sites between SOX4 3′UTR and miR-590-3p were shown. (B) Dual-luciferase reporter assay was used to confirm the interaction between SOX4 and miR-590-3p. (C) AC16 cells were transfected with miR-NC or miR-590-3p mimic, followed by treated with hypoxia. AC16 cells treated with normoxia were used as control. The protein expression of SOX4 was analyzed using WB analysis. (D) AC16 cells were transfected with sh-NC + anti-NC, sh-circ_0124644 + anti-NC, sh-circ_0124644 + anti-miR-590-3p, followed by treated with hypoxia. Normoxia-treated AC16 cells transfected with sh-NC + anti-NC were used as control. WB analysis was used to detect SOX4 protein expression. (E,F) The protein and mRNA expression levels of SOX4 in the serum of AMI patients and healthy control volunteers were evaluated using WB analysis and qRT-PCR. (G,H) The correlation between SOX4 and miR-590-3p or circ_0124644 was assessed by Pearson correlation analysis. ** P < 0.01, *** P < 0.001.

Journal: Frontiers in Genetics

Article Title: Circ_0124644 Serves as a ceRNA for miR-590-3p to Promote Hypoxia-Induced Cardiomyocytes Injury via Regulating SOX4

doi: 10.3389/fgene.2021.667724

Figure Lengend Snippet: SOX4 could be targeted by miR-590-3p. (A) The predicted and mutated binding sites between SOX4 3′UTR and miR-590-3p were shown. (B) Dual-luciferase reporter assay was used to confirm the interaction between SOX4 and miR-590-3p. (C) AC16 cells were transfected with miR-NC or miR-590-3p mimic, followed by treated with hypoxia. AC16 cells treated with normoxia were used as control. The protein expression of SOX4 was analyzed using WB analysis. (D) AC16 cells were transfected with sh-NC + anti-NC, sh-circ_0124644 + anti-NC, sh-circ_0124644 + anti-miR-590-3p, followed by treated with hypoxia. Normoxia-treated AC16 cells transfected with sh-NC + anti-NC were used as control. WB analysis was used to detect SOX4 protein expression. (E,F) The protein and mRNA expression levels of SOX4 in the serum of AMI patients and healthy control volunteers were evaluated using WB analysis and qRT-PCR. (G,H) The correlation between SOX4 and miR-590-3p or circ_0124644 was assessed by Pearson correlation analysis. ** P < 0.01, *** P < 0.001.

Article Snippet: Human cardiomyocytes (AC16) (Biovector National Typical Culture Center, Beijing, China) were cultured in DMEM medium (Gibco, Grand Island, NY, United States) containing 10% fetal bovine serum (FBS; Gibco) and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, United States).

Techniques: Binding Assay, Luciferase, Reporter Assay, Transfection, Control, Expressing, Quantitative RT-PCR

Effects of SOX4 and miR-590-3p overexpression on hypoxia-induced cardiomyocytes injury. (A) WB analysis was used to detect SOX4 protein expression in AC16 cells to evaluate the transfection efficiency of pcDNA SOX4 overexpression vector. (B–I) AC16 cells were transfected with miR-NC + pcDNA, miR-590-3p + pcDNA, or miR-590-3p + SOX4, followed by treated with hypoxia. Normoxia-treated AC16 cells transfected with miR-NC + pcDNA were used as control. (B) Cell viability was detected by CCK8 assay. (C,D) Flow cytometry was utilized for assessing cell cycle distribution and cell apoptosis. (E) WB analysis was used to test the protein levels of CyclinD1 and Cleaved-casp3. (F–I) Corresponding Assay Kits were employed to detect the levels of LDH, MDA, SOD, and CAT. * P < 0.05, ** P < 0.01, *** P < 0.001.

Journal: Frontiers in Genetics

Article Title: Circ_0124644 Serves as a ceRNA for miR-590-3p to Promote Hypoxia-Induced Cardiomyocytes Injury via Regulating SOX4

doi: 10.3389/fgene.2021.667724

Figure Lengend Snippet: Effects of SOX4 and miR-590-3p overexpression on hypoxia-induced cardiomyocytes injury. (A) WB analysis was used to detect SOX4 protein expression in AC16 cells to evaluate the transfection efficiency of pcDNA SOX4 overexpression vector. (B–I) AC16 cells were transfected with miR-NC + pcDNA, miR-590-3p + pcDNA, or miR-590-3p + SOX4, followed by treated with hypoxia. Normoxia-treated AC16 cells transfected with miR-NC + pcDNA were used as control. (B) Cell viability was detected by CCK8 assay. (C,D) Flow cytometry was utilized for assessing cell cycle distribution and cell apoptosis. (E) WB analysis was used to test the protein levels of CyclinD1 and Cleaved-casp3. (F–I) Corresponding Assay Kits were employed to detect the levels of LDH, MDA, SOD, and CAT. * P < 0.05, ** P < 0.01, *** P < 0.001.

Article Snippet: Human cardiomyocytes (AC16) (Biovector National Typical Culture Center, Beijing, China) were cultured in DMEM medium (Gibco, Grand Island, NY, United States) containing 10% fetal bovine serum (FBS; Gibco) and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, United States).

Techniques: Over Expression, Expressing, Transfection, Plasmid Preparation, Control, CCK-8 Assay, Flow Cytometry

Differentially expressed genes in human cardiomyocytes. Numbers of differentially expressed genes after cyclic stretching: ( A ) Genes showing an at least 2-fold difference in expression; ( B ) genes showing an at least 1.5-fold difference in expression. Venn diagrams show the overlapping genes with at least 2-fold and 1.5-fold differences in expression.

Journal: Aging (Albany NY)

Article Title: Systems biology approach to exploring the effect of cyclic stretching on cardiac cell physiology

doi: 10.18632/aging.103465

Figure Lengend Snippet: Differentially expressed genes in human cardiomyocytes. Numbers of differentially expressed genes after cyclic stretching: ( A ) Genes showing an at least 2-fold difference in expression; ( B ) genes showing an at least 1.5-fold difference in expression. Venn diagrams show the overlapping genes with at least 2-fold and 1.5-fold differences in expression.

Article Snippet: Human ventricular cardiomyocyte cells (AC16) were maintained in DMEM/F12 (GeneDireX Incorporation, Taiwan) supplemented with 10% fetal bovine serum (Fisher Scientific, Pittsburgh, PA, USA), 100 IU/mL penicillin (Sigma-Aldrich) and 100 μg/mL streptomycin (Sigma-Aldrich).

Techniques: Expressing

Functional analysis of differentially expressed genes in human cardiomyocytes after 1, 4, 12, 24, and 48 hours of cyclic stretching.

Journal: Aging (Albany NY)

Article Title: Systems biology approach to exploring the effect of cyclic stretching on cardiac cell physiology

doi: 10.18632/aging.103465

Figure Lengend Snippet: Functional analysis of differentially expressed genes in human cardiomyocytes after 1, 4, 12, 24, and 48 hours of cyclic stretching.

Article Snippet: Human ventricular cardiomyocyte cells (AC16) were maintained in DMEM/F12 (GeneDireX Incorporation, Taiwan) supplemented with 10% fetal bovine serum (Fisher Scientific, Pittsburgh, PA, USA), 100 IU/mL penicillin (Sigma-Aldrich) and 100 μg/mL streptomycin (Sigma-Aldrich).

Techniques: Functional Assay

Differential expression profile of 29 genes after 1, 4, 12, 24, and 48 hours of cyclical stretching in human cardiomyocytes. The heat map diagram shows expression changes for 29 genes that were altered in cardiac myocytes in response to at least three time points of mechanical stretching.

Journal: Aging (Albany NY)

Article Title: Systems biology approach to exploring the effect of cyclic stretching on cardiac cell physiology

doi: 10.18632/aging.103465

Figure Lengend Snippet: Differential expression profile of 29 genes after 1, 4, 12, 24, and 48 hours of cyclical stretching in human cardiomyocytes. The heat map diagram shows expression changes for 29 genes that were altered in cardiac myocytes in response to at least three time points of mechanical stretching.

Article Snippet: Human ventricular cardiomyocyte cells (AC16) were maintained in DMEM/F12 (GeneDireX Incorporation, Taiwan) supplemented with 10% fetal bovine serum (Fisher Scientific, Pittsburgh, PA, USA), 100 IU/mL penicillin (Sigma-Aldrich) and 100 μg/mL streptomycin (Sigma-Aldrich).

Techniques: Quantitative Proteomics, Expressing

Comparison of “standard” and “high-resolution” CZE methods. Extracted Ion Electropherograms (EIEs, seven highest charge states each) of sample containing H2BK120ub and H3K4,9,14,18ac analyzed with (a) standard and (b) high-resolution CZE method. Mass spectra (c-f) generated by averaging the EIE peaks at full width at half maximum (FWHM). Partial separation (R = 0.366, n = 2) obtained using standard method and close to baseline separation (R = 1.082, n = 3) achieved for high-resolution method.

Journal: bioRxiv

Article Title: Separation and Characterization of Endogenous Nucleosomes by Native Capillary Zone Electrophoresis – Top-Down Mass Spectrometry (nCZE-TDMS)

doi: 10.1101/2020.11.25.398925

Figure Lengend Snippet: Comparison of “standard” and “high-resolution” CZE methods. Extracted Ion Electropherograms (EIEs, seven highest charge states each) of sample containing H2BK120ub and H3K4,9,14,18ac analyzed with (a) standard and (b) high-resolution CZE method. Mass spectra (c-f) generated by averaging the EIE peaks at full width at half maximum (FWHM). Partial separation (R = 0.366, n = 2) obtained using standard method and close to baseline separation (R = 1.082, n = 3) achieved for high-resolution method.

Article Snippet: All semi-synthetic nucleosomes were from EpiCypher (Durham, NC, USA): unmodified recombinant (r)Nuc (16-0006); H3K27me3 (16-0317), H2BK120ub (16-0370) and H3K4,9,14,18ac (16-0336) designer (d)Nucs; and H3.3G34V (16-0347) oncoNuc.

Techniques: Generated

( A ) Mice underwent sham surgery, STNx, or IRI and were sacrificed at 70 or 147 days after surgery. ( B ) Serum urea, serum creatinine (S-creatinine), heart weight, normalized to tibia length, and ejection fraction at the time point of sacrifice in sham (SH), STNx, and IRI mice. ( C ) Representative trichrome-stained images of kidney and heart. Scale bars, 50 μm. ( D ) UMAP embedding of nuclei isolated from left ventricle of all mice. n = 33,039 nuclei from n = 12 mice. ( E ) Expression of marker genes per cluster (cardiomyocytes: Ryr2 , Dmd , Myh6 , Fhl2 , and Ttn ; endothelial cells: Vwf , Cgnl1 , Smoc1 , Bmx , Pecam1 , Flt1 , Adgrl1 , and Prprb ; fibroblasts: Pdgra , Egfr , Dcn , Gsn , Col3a1 , and Col8a1 ; lymphatic endothelial cells: Flt4 , Prox1 , Lyve1 , and Pdpn ; lymphocytes: Btla , Cd2 , Bcl11b , and Sell ; macrophages: Mrc1 , Lyz2 , Cd86 , Cd68 , and Cd80 ; mesothelial cells: Muc16 , Msln , and Upk3b ; monocytes: Cd45 , Csfr1r; RBC: Lock2 , and Cd36 ; pericytes: Pdgfrb , Notch3 , Mcam , and Rgs5 ; and VSMC : Myh11 , Myl9 , and Lmod ). ( F ) PROGENGY pathway analysis in all cell types, STNx versus sham and IRI versus sham. ( G ) Predicted receptor-ligand interactions per group, sham, STNx, and IRI. * P < 0.05; ** P < 0.001. CM, cardiomyocytes; EC, endothelial cells; Fib, fibroblasts; Lym, lymphocytes; LEC, lymphatic endothelial cells; Mac, macrophages; Mes, mesothelial cells; Mon, monocytes; Per, pericytes; RBC, red blood cells; VSMC, vascular smooth muscle cells.

Journal: Science Advances

Article Title: Mapping cardiac remodeling in chronic kidney disease

doi: 10.1126/sciadv.adj4846

Figure Lengend Snippet: ( A ) Mice underwent sham surgery, STNx, or IRI and were sacrificed at 70 or 147 days after surgery. ( B ) Serum urea, serum creatinine (S-creatinine), heart weight, normalized to tibia length, and ejection fraction at the time point of sacrifice in sham (SH), STNx, and IRI mice. ( C ) Representative trichrome-stained images of kidney and heart. Scale bars, 50 μm. ( D ) UMAP embedding of nuclei isolated from left ventricle of all mice. n = 33,039 nuclei from n = 12 mice. ( E ) Expression of marker genes per cluster (cardiomyocytes: Ryr2 , Dmd , Myh6 , Fhl2 , and Ttn ; endothelial cells: Vwf , Cgnl1 , Smoc1 , Bmx , Pecam1 , Flt1 , Adgrl1 , and Prprb ; fibroblasts: Pdgra , Egfr , Dcn , Gsn , Col3a1 , and Col8a1 ; lymphatic endothelial cells: Flt4 , Prox1 , Lyve1 , and Pdpn ; lymphocytes: Btla , Cd2 , Bcl11b , and Sell ; macrophages: Mrc1 , Lyz2 , Cd86 , Cd68 , and Cd80 ; mesothelial cells: Muc16 , Msln , and Upk3b ; monocytes: Cd45 , Csfr1r; RBC: Lock2 , and Cd36 ; pericytes: Pdgfrb , Notch3 , Mcam , and Rgs5 ; and VSMC : Myh11 , Myl9 , and Lmod ). ( F ) PROGENGY pathway analysis in all cell types, STNx versus sham and IRI versus sham. ( G ) Predicted receptor-ligand interactions per group, sham, STNx, and IRI. * P < 0.05; ** P < 0.001. CM, cardiomyocytes; EC, endothelial cells; Fib, fibroblasts; Lym, lymphocytes; LEC, lymphatic endothelial cells; Mac, macrophages; Mes, mesothelial cells; Mon, monocytes; Per, pericytes; RBC, red blood cells; VSMC, vascular smooth muscle cells.

Article Snippet: Human AC16 cardiomyocytes (Merck Millipore, USA) were cultured in Dulbecco’s modified Eagle’s medium (DMEM)–F12 (D6434 Sigma-Aldrich, Germany) supplemented with 2 mM glutamine (TMS-002-C Millipore, USA), 12.5% fetal bovine serum (ES-009-B Millipore, USA), and 1% penicillin/streptomycin.

Techniques: Staining, Isolation, Expressing, Marker

( A ) Representative confocal images of WGA-stained left ventricular myocardium from mice after sham surgery, STNx, or IRI. Scale bars, 20 μm. ( B ) Feret diameter of cardiomyocytes from sham, STNx, and IRI mice. ( C ) Hypertrophy gene set enrichment in cardiomyocytes 1 to 4 from sham, STNx, and IRI mice (GSEA). ( D ) Diffusion map (DM) embedding of cardiomyocytes 1 to 4 from sham, STNx, and IRI mice color-coded per condition, ( E ) See (D) but color-coded per cardiomyocyte cluster. ( F ) Differentiation trajectory toward hypertrophic cardiomyocytes within DM from (D) to (E). ( G ) Hypertrophy gene set enrichment in DM of cardiomyocytes from (D) to (E). ( H ) Genes sorted along the pseudotime trajectory of cardiomyocyte hypertrophy in (F); the color represents z score of the log-normalized gene expression across pseudotime (0 to 100) cells. ( I ) GO terms sorted along the pseudotime trajectory of cardiomyocyte hypertrophy in (F); the color represents the −log 10 transformed P value of GO terms derived from highly expressed genes across pseudotime (one to five) cells. ( J ) AC16 cardiomyocyte cell line, treated with 5 or 10% uremic serum, compared to healthy serum; planimetric analysis of cross-sectional area per cardiomyocyte from fluorescence microscopic images, TMRM staining. ( K ) Hypertrophic gene set, expressed in AC16 cells after treatment with 5% healthy or 5% uremic serum. ( L ) PROGENY pathway analysis in AC16 cells after treatment with 5% healthy or 5% uremic serum. ( M ) Planimetric analysis of cross-sectional area per cardiomyocyte from fluorescence microscopic images, TMRM staining, cells either treated with healthy serum, uremic serum + vehicle, uremic serum + ruxolitinib, or uremic serum + etanercept. * P < 0.05; # P < 0.001.

Journal: Science Advances

Article Title: Mapping cardiac remodeling in chronic kidney disease

doi: 10.1126/sciadv.adj4846

Figure Lengend Snippet: ( A ) Representative confocal images of WGA-stained left ventricular myocardium from mice after sham surgery, STNx, or IRI. Scale bars, 20 μm. ( B ) Feret diameter of cardiomyocytes from sham, STNx, and IRI mice. ( C ) Hypertrophy gene set enrichment in cardiomyocytes 1 to 4 from sham, STNx, and IRI mice (GSEA). ( D ) Diffusion map (DM) embedding of cardiomyocytes 1 to 4 from sham, STNx, and IRI mice color-coded per condition, ( E ) See (D) but color-coded per cardiomyocyte cluster. ( F ) Differentiation trajectory toward hypertrophic cardiomyocytes within DM from (D) to (E). ( G ) Hypertrophy gene set enrichment in DM of cardiomyocytes from (D) to (E). ( H ) Genes sorted along the pseudotime trajectory of cardiomyocyte hypertrophy in (F); the color represents z score of the log-normalized gene expression across pseudotime (0 to 100) cells. ( I ) GO terms sorted along the pseudotime trajectory of cardiomyocyte hypertrophy in (F); the color represents the −log 10 transformed P value of GO terms derived from highly expressed genes across pseudotime (one to five) cells. ( J ) AC16 cardiomyocyte cell line, treated with 5 or 10% uremic serum, compared to healthy serum; planimetric analysis of cross-sectional area per cardiomyocyte from fluorescence microscopic images, TMRM staining. ( K ) Hypertrophic gene set, expressed in AC16 cells after treatment with 5% healthy or 5% uremic serum. ( L ) PROGENY pathway analysis in AC16 cells after treatment with 5% healthy or 5% uremic serum. ( M ) Planimetric analysis of cross-sectional area per cardiomyocyte from fluorescence microscopic images, TMRM staining, cells either treated with healthy serum, uremic serum + vehicle, uremic serum + ruxolitinib, or uremic serum + etanercept. * P < 0.05; # P < 0.001.

Article Snippet: Human AC16 cardiomyocytes (Merck Millipore, USA) were cultured in Dulbecco’s modified Eagle’s medium (DMEM)–F12 (D6434 Sigma-Aldrich, Germany) supplemented with 2 mM glutamine (TMS-002-C Millipore, USA), 12.5% fetal bovine serum (ES-009-B Millipore, USA), and 1% penicillin/streptomycin.

Techniques: Staining, Diffusion-based Assay, Gene Expression, Transformation Assay, Derivative Assay, Fluorescence

( A ) Gene set enrichment of genes associated to UTs on all cell types; STNx versus sham (IRI versus sham is shown in fig. S13). ( B ) HUVEC tube formation assay, treatment with 5 or 10% uremic serum versus healthy control serum, quantification of isolated branches and bright-field microscopic images. ( C ) HUVEC tube formation assay, treatment with endothelin 1 (Edn1) or endothelin 1 neutralizing antibody, quantification of total mesh area and bright-field microscopic images. Scale bars, 500 μm. Sham: # P < 0.001. ( D ) Expression of endothelin converting enzyme 1 ( Ece1 ) in lymphatic endothelial cells and endothelial cells 1 to 3, per treatment group. ( E ) Size of AC16 cells after treatment with Edn1 or vehicle for 3 days. Scale bars, 25 μm.

Journal: Science Advances

Article Title: Mapping cardiac remodeling in chronic kidney disease

doi: 10.1126/sciadv.adj4846

Figure Lengend Snippet: ( A ) Gene set enrichment of genes associated to UTs on all cell types; STNx versus sham (IRI versus sham is shown in fig. S13). ( B ) HUVEC tube formation assay, treatment with 5 or 10% uremic serum versus healthy control serum, quantification of isolated branches and bright-field microscopic images. ( C ) HUVEC tube formation assay, treatment with endothelin 1 (Edn1) or endothelin 1 neutralizing antibody, quantification of total mesh area and bright-field microscopic images. Scale bars, 500 μm. Sham: # P < 0.001. ( D ) Expression of endothelin converting enzyme 1 ( Ece1 ) in lymphatic endothelial cells and endothelial cells 1 to 3, per treatment group. ( E ) Size of AC16 cells after treatment with Edn1 or vehicle for 3 days. Scale bars, 25 μm.

Article Snippet: Human AC16 cardiomyocytes (Merck Millipore, USA) were cultured in Dulbecco’s modified Eagle’s medium (DMEM)–F12 (D6434 Sigma-Aldrich, Germany) supplemented with 2 mM glutamine (TMS-002-C Millipore, USA), 12.5% fetal bovine serum (ES-009-B Millipore, USA), and 1% penicillin/streptomycin.

Techniques: HUVEC Tube Formation Assay, Control, Isolation, Expressing

Protection of hypoxic human cardiomyocytes using CMSCLC and BM-MSC EVs ( A ) Experimental design showing hiPSC-CM seeding and hypoxia treatment. ( B ) Example images of hiPSC-CMs following 48 h normoxia or hypoxia + vehicle (Veh), or hypoxia with 67 ng/µl CMSCLC EVs (C_EVs) or BM-MSC EVs (B_EVs). Scale bar 100 μm. ( C ) Culture medium LDH levels after 48 h of hiPSC-CM exposure to each treatment group. Blank samples (without hiPSC-CMs) are also included. Hypoxic hiPSC-CM groups were compared by one-way ANOVA with Tukey’s multiple comparison test. *** = P ≤ 0.001, **** = P ≤ 0.0001 ( D ) Apoptosis protein arrays from each group ( n = 2 per group). Examples of significant differences between samples are highlighted with red boxes. Positive controls are shown as blue boxes in the upper left and lower right corners. ( E ) Heatmap showing quantification of integrated density of high concentration apoptosis-related proteins ( n = 2 per group). All groups were compared using two-way ANOVA with Tukey’s post-test. The table above the heat map describes statistical significance; 1 = P < 0.05, 2 = P ≤ 0.01, 3 = P ≤ 0.001, 4 = P ≤ 0.0001, ns = not significant ( P > 0.05)

Journal: Stem Cell Research & Therapy

Article Title: Extracellular vesicles from human cardiac stromal cells up-regulate cardiomyocyte protective responses to hypoxia

doi: 10.1186/s13287-024-03983-y

Figure Lengend Snippet: Protection of hypoxic human cardiomyocytes using CMSCLC and BM-MSC EVs ( A ) Experimental design showing hiPSC-CM seeding and hypoxia treatment. ( B ) Example images of hiPSC-CMs following 48 h normoxia or hypoxia + vehicle (Veh), or hypoxia with 67 ng/µl CMSCLC EVs (C_EVs) or BM-MSC EVs (B_EVs). Scale bar 100 μm. ( C ) Culture medium LDH levels after 48 h of hiPSC-CM exposure to each treatment group. Blank samples (without hiPSC-CMs) are also included. Hypoxic hiPSC-CM groups were compared by one-way ANOVA with Tukey’s multiple comparison test. *** = P ≤ 0.001, **** = P ≤ 0.0001 ( D ) Apoptosis protein arrays from each group ( n = 2 per group). Examples of significant differences between samples are highlighted with red boxes. Positive controls are shown as blue boxes in the upper left and lower right corners. ( E ) Heatmap showing quantification of integrated density of high concentration apoptosis-related proteins ( n = 2 per group). All groups were compared using two-way ANOVA with Tukey’s post-test. The table above the heat map describes statistical significance; 1 = P < 0.05, 2 = P ≤ 0.01, 3 = P ≤ 0.001, 4 = P ≤ 0.0001, ns = not significant ( P > 0.05)

Article Snippet: Rat cardiac H9C2 cells (Taiwan BCRC, 60096) and human cardiomyocytes (AC16 Merck, SCC109) were used for some supporting experiments and their viability was measured by CCK-8 and LDH assays by the same methods.

Techniques: Comparison, Concentration Assay

RNA sequencing of hypoxic EV-treated human cardiomyocytes. ( A ) Principal component analysis (PCA) for normoxia, hypoxia + vehicle (Hyp), hypoxia + CMSCLC EV (H + C_EV) and BM-MSC EV groups (H + B_EV). ( B ) TPM distribution of all gene transcripts or ( C ) protein-coding gene transcripts for the four experimental groups. Sample distributions were compared by Kolmogorov-Smirnov (KS) test, and the direction of change and P values are shown for each comparison. ( D ) Venn diagrams showing the number of overlapping genes between the stated comparisons. ( E ) Volcano plot of hypoxia + vehicle against hypoxia + C_EVs. The Y axis show statistical significance, with the solid line showing P = 0.05. The X axis shows log2 fold change with the red and green lines showing two-fold down- and up-regulation respectively. ( F ) Scatter plot of hypoxia + vehicle vs. hypoxia + C_EV. Each point represents one gene. Green points indicate P ≤ 0.05 and the box indicates the genes with ≥ 0.3 TPM which were included in subsequent analyses. ( G ) Pyramid plot of most significantly enriched pathways by KEGG for hypoxia + C_EV vs. hypoxia + vehicle. The X axis shows the number of upregulated and downregulated genes in each group and the bar colours indicate statistical significance. ( H ) Pyramid plot of molecular function (MF). ( I ) Scatter plot showing the 10 most differentially-expressed and most statistically significant genes ( J ) between hypoxia + vehicle vs. hypoxia + C_EV groups

Journal: Stem Cell Research & Therapy

Article Title: Extracellular vesicles from human cardiac stromal cells up-regulate cardiomyocyte protective responses to hypoxia

doi: 10.1186/s13287-024-03983-y

Figure Lengend Snippet: RNA sequencing of hypoxic EV-treated human cardiomyocytes. ( A ) Principal component analysis (PCA) for normoxia, hypoxia + vehicle (Hyp), hypoxia + CMSCLC EV (H + C_EV) and BM-MSC EV groups (H + B_EV). ( B ) TPM distribution of all gene transcripts or ( C ) protein-coding gene transcripts for the four experimental groups. Sample distributions were compared by Kolmogorov-Smirnov (KS) test, and the direction of change and P values are shown for each comparison. ( D ) Venn diagrams showing the number of overlapping genes between the stated comparisons. ( E ) Volcano plot of hypoxia + vehicle against hypoxia + C_EVs. The Y axis show statistical significance, with the solid line showing P = 0.05. The X axis shows log2 fold change with the red and green lines showing two-fold down- and up-regulation respectively. ( F ) Scatter plot of hypoxia + vehicle vs. hypoxia + C_EV. Each point represents one gene. Green points indicate P ≤ 0.05 and the box indicates the genes with ≥ 0.3 TPM which were included in subsequent analyses. ( G ) Pyramid plot of most significantly enriched pathways by KEGG for hypoxia + C_EV vs. hypoxia + vehicle. The X axis shows the number of upregulated and downregulated genes in each group and the bar colours indicate statistical significance. ( H ) Pyramid plot of molecular function (MF). ( I ) Scatter plot showing the 10 most differentially-expressed and most statistically significant genes ( J ) between hypoxia + vehicle vs. hypoxia + C_EV groups

Article Snippet: Rat cardiac H9C2 cells (Taiwan BCRC, 60096) and human cardiomyocytes (AC16 Merck, SCC109) were used for some supporting experiments and their viability was measured by CCK-8 and LDH assays by the same methods.

Techniques: RNA Sequencing Assay, Comparison

Determining hypoxia protection by abundant EV miRNAs. ( A ) CCK-8 activity of hypoxic AC16 cardiomyocytes incubated with miRNA negative control (miR-NEG), single miRNA mimics or combinations of mimics to a total of 15 nM. Percentages are relative to normoxia. ( B ) LDH secretion shown as change in absorbance relative to normoxia. Groups were compared to miR-NEG by one-way ANOVA with Dunnett’s multiple comparison test. * = P < 0.05, **** = P ≤ 0.0001. N = 24 samples per group. ( C ) Representative images from selected conditions. ( D ) Gene expression of predicted miRNA targets after normoxia, hypoxia + miR-NEG, miR-1260a or miR-142/202/451 at 15 nM. The Y axis shows log scale of gene expression normalised to GAPDH. N = 4 independent samples per bar. Statistical annotations show comparisons against hypoxia + miR-NEG by one-way ANOVA with Dunnett’s multiple comparison test. * = P < 0.05, ** = P ≤ 0.01

Journal: Stem Cell Research & Therapy

Article Title: Extracellular vesicles from human cardiac stromal cells up-regulate cardiomyocyte protective responses to hypoxia

doi: 10.1186/s13287-024-03983-y

Figure Lengend Snippet: Determining hypoxia protection by abundant EV miRNAs. ( A ) CCK-8 activity of hypoxic AC16 cardiomyocytes incubated with miRNA negative control (miR-NEG), single miRNA mimics or combinations of mimics to a total of 15 nM. Percentages are relative to normoxia. ( B ) LDH secretion shown as change in absorbance relative to normoxia. Groups were compared to miR-NEG by one-way ANOVA with Dunnett’s multiple comparison test. * = P < 0.05, **** = P ≤ 0.0001. N = 24 samples per group. ( C ) Representative images from selected conditions. ( D ) Gene expression of predicted miRNA targets after normoxia, hypoxia + miR-NEG, miR-1260a or miR-142/202/451 at 15 nM. The Y axis shows log scale of gene expression normalised to GAPDH. N = 4 independent samples per bar. Statistical annotations show comparisons against hypoxia + miR-NEG by one-way ANOVA with Dunnett’s multiple comparison test. * = P < 0.05, ** = P ≤ 0.01

Article Snippet: Rat cardiac H9C2 cells (Taiwan BCRC, 60096) and human cardiomyocytes (AC16 Merck, SCC109) were used for some supporting experiments and their viability was measured by CCK-8 and LDH assays by the same methods.

Techniques: CCK-8 Assay, Activity Assay, Incubation, Negative Control, Comparison, Expressing